Enteropathy-type (intestinal) T-cell lymphoma, in remission is a rare form of non-Hodgkin lymphoma characterized by the proliferation of T-cells in the intestinal mucosa. It is often associated with celiac disease or other enteropathies. Accurate coding with ICD-10 Code C86.21 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.
ICD-10 Code C86.21 represents Enteropathy-type (intestinal) T-cell lymphoma, in remission, a condition where malignant T-cells infiltrate the intestinal mucosa, often linked to chronic intestinal inflammation. This code is used when the patient is in remission, indicating a response to treatment. It is crucial for clinical documentation and billing to reflect the patient's current health status accurately.
Enteropathy-type (intestinal) T-cell lymphoma, in remission, is a hematological malignancy that arises from the transformation of intestinal intraepithelial lymphocytes into malignant T-cells. This condition often progresses from chronic intestinal inflammation and requires prompt medical attention due to its potential complications.
ICD-10 Code C86.21 is utilized in SOAP notes to document the patient's remission status, guiding treatment plans and follow-up care. It plays a vital role in both acute and chronic care settings, ensuring comprehensive patient management and accurate billing.
In SOAP notes, ICD-10 Code C86.21 connects subjective patient reports and objective clinical findings to a formal diagnosis of Enteropathy-type (intestinal) T-cell lymphoma, in remission. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Management of Enteropathy-type (intestinal) T-cell lymphoma, in remission, focuses on maintaining remission and monitoring for recurrence.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C86.21 is crucial for accurate billing in hospital, ER, or infectious disease care settings.
| CPT Code | Description |
|---|---|
| 99214 | Established patient office visit, moderate complexity. |
| 85025 | Complete blood count with differential. |
| 74176 | CT abdomen and pelvis with contrast. |
| 96413 | Chemotherapy administration, intravenous. |
Common Questions About Using ICD-10 Code C86.21 for Enteropathy-type (intestinal) T-cell lymphoma, in remission
What does it mean for Enteropathy-type T-cell lymphoma to be in remission?
Remission indicates that the signs and symptoms of Enteropathy-type T-cell lymphoma have significantly decreased or are no longer present, often as a result of effective treatment. Regular monitoring is essential to ensure that the disease does not recur.
How is Enteropathy-type T-cell lymphoma diagnosed?
Diagnosis typically involves a combination of clinical evaluation, imaging studies, and biopsy of intestinal tissue to identify atypical T-cells. Laboratory tests may also be conducted to assess overall health and rule out other conditions.
What are the common treatments for Enteropathy-type T-cell lymphoma?
Treatment often includes chemotherapy, immunotherapy, and supportive care to manage symptoms. Nutritional support is also critical, especially for patients with malabsorption issues related to the disease.
How often should patients with Enteropathy-type T-cell lymphoma in remission be monitored?
Patients should have regular follow-up appointments, typically every 3 to 6 months, to monitor for any signs of recurrence and to manage any ongoing symptoms or complications.
Clinical Notes
SOAP notes
DAP notes
AI medical notes